The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, S.
Right arrow Articles by Pernis, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, S.
Right arrow Articles by Pernis, A. B.
The Journal of Immunology, 1999, 163: 3834-3841.
Copyright © 1999 by The American Association of Immunologists

IFN-{alpha} Activates Stat6 and Leads to the Formation of Stat2:Stat6 Complexes in B Cells1

Sanjay Gupta, Man Jiang and Alessandra B. Pernis2

Department of Medicine, Columbia University, New York, NY 10032

IFN-{alpha} consists of a family of highly homologous proteins, which exert pleiotropic effects on a wide variety of cell types. The biologic activities of IFN-{alpha} are mediated by its binding to a multicomponent receptor complex resulting in the activation of the Janus kinase-STAT signaling pathway. In most cell types, activation of Stat1 and Stat2 by IFN-{alpha} leads to the formation of either STAT homo-/heterodimers or of the IFN-stimulated gene factor 3 complex composed of Stat1, Stat2, and p48, a non-STAT protein. These distinct transcriptional complexes then target two different sets of cis-elements, {gamma}-activated sites and IFN-stimulated response elements. Here, we report that IFN-{alpha} can activate complexes containing Stat6, which, until now, has been primarily associated with signaling by two cytokines with biologic overlap, IL-4 and IL-13. Induction of Stat6 complexes by IFN-{alpha} appears to be cell type specific, given that tyrosine phosphorylation of Stat6 in response to IFN-{alpha} is predominantly detected in B cells. Activation of Stat6 by IFN-{alpha} in B cells is accompanied by the formation of novel Stat2:Stat6 complexes, including an IFN-stimulated gene factor 3-like complex containing Stat2, Stat6, and p48. B cell lines resistant to the antiproliferative effects of IFN-{alpha} display a decrease in the IFN-{alpha}-mediated activation of Stat6. Activation of Stat6 as well as of Stat2:Stat6 complexes by IFN-{alpha} in B cells may allow modulation of target genes in a cell type-specific manner.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Honma, D. Kimura, N. Tominaga, M. Miyakoda, T. Matsuyama, and K. Yui
Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells
PNAS, October 14, 2008; 105(41): 15890 - 15895.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. Arguni, M. Arima, N. Tsuruoka, A. Sakamoto, M. Hatano, and T. Tokuhisa
JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells
Int. Immunol., July 1, 2006; 18(7): 1079 - 1089.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Severa, M. E. Remoli, E. Giacomini, J. Ragimbeau, R. Lande, G. Uze, S. Pellegrini, and E. M. Coccia
Differential responsiveness to IFN-{alpha} and IFN-{beta} of human mature DC through modulation of IFNAR expression
J. Leukoc. Biol., June 1, 2006; 79(6): 1286 - 1294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L.-J. Ho, L.-F. Hung, C.-Y. Weng, W.-L. Wu, P. Chou, Y.-L. Lin, D.-M. Chang, T.-Y. Tai, and J.-H. Lai
Dengue Virus Type 2 Antagonizes IFN-{alpha} but Not IFN-{gamma} Antiviral Effect via Down-Regulating Tyk2-STAT Signaling in the Human Dendritic Cell
J. Immunol., June 15, 2005; 174(12): 8163 - 8172.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Liang, Y. C. Shin, R. E. Means, and J. U. Jung
Inhibition of Interferon-Mediated Antiviral Activity by Murine Gammaherpesvirus 68 Latency-Associated M2 Protein
J. Virol., November 15, 2004; 78(22): 12416 - 12427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. He, X. Qiao, and A. Cerutti
CpG DNA Induces IgG Class Switch DNA Recombination by Activating Human B Cells through an Innate Pathway That Requires TLR9 and Cooperates with IL-10
J. Immunol., October 1, 2004; 173(7): 4479 - 4491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Eriksen, V. H. Sommer, A. Woetmann, A. B. Rasmussen, C. Brender, A. Svejgaard, S. Skov, C. Geisler, and N. Odum
Bi-phasic Effect of Interferon (IFN)-{alpha}: IFN-{alpha} UP- AND DOWN-REGULATES INTERLEUKIN-4 SIGNALING IN HUMAN T CELLS
J. Biol. Chem., January 2, 2004; 279(1): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. U. Hilkens, J. F. Schlaak, and I. M. Kerr
Differential Responses to IFN-{alpha} Subtypes in Human T Cells and Dendritic Cells
J. Immunol., November 15, 2003; 171(10): 5255 - 5263.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Mora, L. M. Stephenson, B. Enerson, J. Youn, A. D. Keegan, and M. Boothby
New Programming of IL-4 Receptor Signal Transduction in Activated T Cells: Stat6 Induction and Th2 Differentiation Mediated by IL-4R{alpha} Lacking Cytoplasmic Tyrosines
J. Immunol., August 15, 2003; 171(4): 1891 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Chen, L. Hutt-Fletcher, L. Cao, and S. D. Hayward
A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus
J. Virol., April 1, 2003; 77(7): 4139 - 4148.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Remoli, E. Giacomini, G. Lutfalla, E. Dondi, G. Orefici, A. Battistini, G. Uze, S. Pellegrini, and E. M. Coccia
Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis
J. Immunol., July 1, 2002; 169(1): 366 - 374.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.